Global Basal Cell Carcinoma Treatment Market: North America Expected to Remain Dominant Until 2025

Published on : Mar 09, 2018

Albany, New York, March 9, 2018: Basal Cell Carcinoma (BCC) is the most common skin cancer in humans. In the present time, the increase in geriatric population, who are highly susceptible to several types of skin diseases, such as actinic keratosis and various other non-melanoma skin malignancies is influencing the demand for basal cell carcinoma treatment tremendously across the world. Market Research Hub (MRH) has freshly publicized a study titled “Basal Cell Carcinoma Treatment Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2017 – 2025” to its vast archive, which believes that progressing at a CAGR of 9.20% over the period from 2017 to 2025, the market is likely to reach US$10.14 bn by 2025 end.

The above findings are based on primary and secondary research. In order to provide a comprehensive view of the global basal cell carcinoma treatment market, a detailed qualitative analysis of factors responsible for driving and restraining market growth and future opportunities have been provided in the market overview section. The market overview section of the study includes market snapshot that provides overall information of various segments and sub-segments.

Geographical and Segmental Overview

Moreover, geographical scenario of the market has been offered to the readers in which the report has computed its market size forecasts in terms of volumes (tons) across various geographies, such as North America, Latin America, Europe, MEA and Asia Pacific. In a bid to offer detailed insights to readers, the report has divided global market analysis into various segments which are based on type of treatment and end-user.

According to the study, North America is projected to continue on the top in the near future. The presence of a well-established medical and healthcare infrastructure, increasing expenditure on healthcare, and the high prevalence of basal cell carcinoma in this region are likely to boost the growth of the market for basal cell carcinoma treatment in North America.

Based on the type of the treatment, the market is classified into surgeries, drugs, and several other types of treatments. Excision, electrodessication and cutterage (ED&C), cryosurgery and Moh's surgery are the most prominent types of surgeries used for the treatment of basal cell carcinoma. By several researches by doctors, it has been analyzed that surgeries are more effective among all the treatment methods for basal cell carcinoma, leading to their high demand.

By end-user, the market has been segmented into specialty clinics, hospitals and others. Of these, Hospitals segment is expected to remain dominant during the forecast period.

At last, the concluding section of the report deals with the company market share analysis of key players operating in this industry including Merck & Co., Inc., Valeant Pharmaceuticals International, Inc., Mylan N.V., F. Hoffmann-La Roche Ltd., and Sun Pharmaceuticals Ltd.

Request a Sample with TOC in a PDF format :

About Market Research Hub

Market Research Hub (MRH) is a next-generation reseller of research reports and analysis. MRH’s expansive collection of market research reports has been carefully curated to help key personnel and decision makers across industry verticals to clearly visualize their operating environment and take strategic steps.

MRH functions as an integrated platform for the following products and services: Objective and sound market forecasts, qualitative and quantitative analysis, incisive insight into defining industry trends, and market share estimates. Our reputation lies in delivering value and world-class capabilities to our clients.

Research Assistance

For Enquiries, Call :

+1-800-998-4852US Toll Free

Email :

Back To Top